Helius Historical Income Statement

HSDT Stock

USD 0.45 0.02 5.35%

Historical analysis of Helius Medical income statement accounts such as Other Operating Expenses of 16.1 M or Research Development of 2.8 M can show how well Helius Medical Technologies performed in making a profits. Evaluating Helius Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Helius Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Helius Medical Techn latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Helius Medical Techn is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

About Helius Income Statement Analysis

Helius Medical Techn Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Helius Medical shareholders. The income statement also shows Helius investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Helius Medical Income Statement Chart

At this time, Helius Medical's Reconciled Depreciation is comparatively stable compared to the past year.

Selling General Administrative Research Development Total Operating Expenses Interest Income

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most accounts from Helius Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Helius Medical Techn current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helius Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

At this time, Helius Medical's Reconciled Depreciation is comparatively stable compared to the past year.

Helius Medical income statement Correlations

	Interest Expense	Selling General Administrative	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Net Income	Income Tax Expense	Gross Profit	Net Income From Continuing Ops	Cost Of Revenue	Non Recurring	Total Other Income Expense Net	Depreciation And Amortization	Selling And Marketing Expenses	Non Operating Income Net Other	Net Interest Income	Interest Income	Reconciled Depreciation
Interest Expense		0.55	0.61	-0.61	-0.83	0.53	-0.83	0.6	-0.19	0.22	-0.31	0.64	-0.22	0.48	0.24	0.65	0.02	0.14	0.67	-0.1	0.19	0.08
Selling General Administrative	0.55		0.93	-0.91	-0.91	0.54	-0.9	0.93	-0.62	-0.33	0.04	0.88	-0.69	0.58	0.63	0.38	0.59	-0.11	0.37	-0.24	0.59	0.48
Other Operating Expenses	0.61	0.93		-0.99	-0.9	0.79	-0.9	1.0	-0.79	-0.5	0.18	0.75	-0.81	0.42	0.61	0.21	0.45	-0.06	0.22	-0.21	0.41	0.33
Operating Income	-0.61	-0.91	-0.99		0.89	-0.84	0.89	-0.99	0.83	0.54	-0.21	-0.73	0.82	-0.35	-0.58	-0.15	-0.41	-0.03	-0.19	0.23	-0.34	-0.28
Ebit	-0.83	-0.91	-0.9	0.89		-0.63	1.0	-0.89	0.51	0.12	0.19	-0.87	0.53	-0.59	-0.46	-0.55	-0.4	-0.04	-0.58	0.2	-0.46	-0.35
Research Development	0.53	0.54	0.79	-0.84	-0.63		-0.63	0.81	-0.88	-0.67	0.35	0.36	-0.75	-0.08	0.31	-0.19	0.05	0.27	-0.1	-0.17	-0.11	-0.08
Ebitda	-0.83	-0.9	-0.9	0.89	1.0	-0.63		-0.89	0.51	0.12	0.19	-0.86	0.52	-0.58	-0.46	-0.55	-0.38	-0.04	-0.58	0.2	-0.44	-0.33
Total Operating Expenses	0.6	0.93	1.0	-0.99	-0.89	0.81	-0.89		-0.81	-0.52	0.2	0.73	-0.82	0.39	0.6	0.18	0.43	-0.05	0.2	-0.2	0.39	0.31
Income Before Tax	-0.19	-0.62	-0.79	0.83	0.51	-0.88	0.51	-0.81		0.91	-0.57	-0.37	0.91	0.12	-0.43	0.42	-0.3	-0.16	0.36	0.26	-0.02	-0.09
Net Income	0.22	-0.33	-0.5	0.54	0.12	-0.67	0.12	-0.52	0.91		-0.74	-0.03	0.81	0.36	-0.31	0.73	-0.21	-0.1	0.69	0.17	0.12	0.0
Income Tax Expense	-0.31	0.04	0.18	-0.21	0.19	0.35	0.19	0.2	-0.57	-0.74		-0.25	-0.71	-0.29	0.48	-0.68	0.1	-0.11	-0.73	-0.01	-0.1	-0.02
Gross Profit	0.64	0.88	0.75	-0.73	-0.87	0.36	-0.86	0.73	-0.37	-0.03	-0.25		-0.39	0.55	0.33	0.53	0.56	0.12	0.58	-0.4	0.52	0.51
Net Income From Continuing Ops	-0.22	-0.69	-0.81	0.82	0.53	-0.75	0.52	-0.82	0.91	0.81	-0.71	-0.39		-0.12	-0.71	0.28	-0.41	0.07	0.3	0.19	-0.24	-0.24
Cost Of Revenue	0.48	0.58	0.42	-0.35	-0.59	-0.08	-0.58	0.39	0.12	0.36	-0.29	0.55	-0.12		0.54	0.77	0.58	-0.5	0.64	-0.09	0.91	0.69
Non Recurring	0.24	0.63	0.61	-0.58	-0.46	0.31	-0.46	0.6	-0.43	-0.31	0.48	0.33	-0.71	0.54		0.17	0.49	-0.35	0.04	-0.09	0.56	0.46
Total Other Income Expense Net	0.65	0.38	0.21	-0.15	-0.55	-0.19	-0.55	0.18	0.42	0.73	-0.68	0.53	0.28	0.77	0.17		0.14	-0.23	0.95	0.09	0.51	0.28
Depreciation And Amortization	0.02	0.59	0.45	-0.41	-0.4	0.05	-0.38	0.43	-0.3	-0.21	0.1	0.56	-0.41	0.58	0.49	0.14		-0.15	0.15	-0.35	0.81	0.94
Selling And Marketing Expenses	0.14	-0.11	-0.06	-0.03	-0.04	0.27	-0.04	-0.05	-0.16	-0.1	-0.11	0.12	0.07	-0.5	-0.35	-0.23	-0.15		0.01	-0.44	-0.54	-0.25
Non Operating Income Net Other	0.67	0.37	0.22	-0.19	-0.58	-0.1	-0.58	0.2	0.36	0.69	-0.73	0.58	0.3	0.64	0.04	0.95	0.15	0.01		-0.03	0.39	0.25
Net Interest Income	-0.1	-0.24	-0.21	0.23	0.2	-0.17	0.2	-0.2	0.26	0.17	-0.01	-0.4	0.19	-0.09	-0.09	0.09	-0.35	-0.44	-0.03		-0.14	-0.26
Interest Income	0.19	0.59	0.41	-0.34	-0.46	-0.11	-0.44	0.39	-0.02	0.12	-0.1	0.52	-0.24	0.91	0.56	0.51	0.81	-0.54	0.39	-0.14		0.84
Reconciled Depreciation	0.08	0.48	0.33	-0.28	-0.35	-0.08	-0.33	0.31	-0.09	0.0	-0.02	0.51	-0.24	0.69	0.46	0.28	0.94	-0.25	0.25	-0.26	0.84

Click cells to compare fundamentals

Helius Medical Account Relationship Matchups

Helius Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	14.2M	256K	10K	834K	257K	244.2K
Selling General Administrative	16.5M	9.7M	12.2M	10.6M	9.6M	9.6M
Other Operating Expenses	25.5M	15.0M	18.7M	15.5M	13.1M	16.1M
Operating Income	(24.0M)	(14.4M)	(18.1M)	(14.8M)	(12.4M)	(13.0M)
Ebit	(38.1M)	(14.4M)	(18.2M)	(14.8M)	(12.3M)	(12.9M)
Research Development	8.1M	4.6M	6.0M	4.3M	2.9M	2.8M
Ebitda	(37.9M)	(13.9M)	(17.8M)	(14.5M)	(12.1M)	(12.7M)
Total Operating Expenses	24.6M	14.7M	18.4M	15.1M	12.5M	15.9M
Income Before Tax	(9.8M)	(14.1M)	(18.1M)	(14.1M)	(8.9M)	(9.3M)
Net Income	4.3M	(13.9M)	(18.1M)	(12.6M)	(8.9M)	(9.3M)
Income Tax Expense	(14.1M)	(193K)	(10K)	(1.5M)	(5.9K)	(6.2K)
Total Revenue	1.5M	661K	522K	787K	644K	458.8K
Gross Profit	650K	273K	224K	324K	61K	58.0K
Net Income From Continuing Ops	(9.8M)	(14.1M)	(18.1M)	(14.1M)	(12.7M)	(13.3M)
Cost Of Revenue	846K	388K	298K	463K	583K	612.2K
Total Other Income Expense Net	14.2M	72K	10K	687K	3.6M	3.8M
Net Income Applicable To Common Shares	(9.8M)	(14.1M)	(18.1M)	(14.1M)	(12.7M)	(13.3M)
Depreciation And Amortization	171.9K	482K	374K	306K	162K	214.2K
Reconciled Depreciation	191K	482K	200K	255K	181K	217.6K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Helius Historical Income Statement

About Helius Income Statement Analysis

Helius Medical Income Statement Chart

Total Operating Expenses

Interest Income

Helius Medical income statement Correlations

Helius Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Helius Medical income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Helius Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Non Operating Income Net Other	+ 0.95	Total Other Income Expense Net
Reconciled Depreciation	+ 0.94	Depreciation And Amortization
Other Operating Expenses	+ 0.93	Selling General Administrative
Total Operating Expenses	+ 0.93	Selling General Administrative

Total Operating Expenses	- 0.99	Operating Income
Operating Income	- 0.99	Other Operating Expenses
Ebit	- 0.91	Selling General Administrative
Operating Income	- 0.91	Selling General Administrative
Ebitda	- 0.9	Other Operating Expenses
Ebit	- 0.9	Other Operating Expenses